Shares of Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.97 and traded as low as $0.70. Biomerica shares last traded at $0.72, with a volume of 59,331 shares trading hands.
Biomerica Stock Down 1.2 %
The business’s 50-day moving average price is $0.97 and its 200 day moving average price is $0.96. The company has a market capitalization of $11.99 million, a P/E ratio of -1.93 and a beta of -1.04.
Biomerica (NASDAQ:BMRA – Get Free Report) last released its quarterly earnings data on Friday, April 12th. The company reported ($0.11) EPS for the quarter. Biomerica had a negative net margin of 117.46% and a negative return on equity of 64.00%. The firm had revenue of $1.02 million during the quarter.
Hedge Funds Weigh In On Biomerica
About Biomerica
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Further Reading
- Five stocks we like better than Biomerica
- Energy and Oil Stocks Explained
- High-Yield Texas Instruments Could Hit New Highs Soon
- ESG Stocks, What Investors Should Know
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Why Are Stock Sectors Important to Successful Investing?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.